{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T02:28:16Z","timestamp":1776824896139,"version":"3.51.2"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:00:00Z","timestamp":1723766400000},"content-version":"am","delay-in-days":320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["NRF-2022R1C1C1005415"],"award-info":[{"award-number":["NRF-2022R1C1C1005415"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.radonc.2023.109841","type":"journal-article","created":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T23:01:51Z","timestamp":1691103711000},"page":"109841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["External validation of subclassification system and progression pattern analysis in hepatocelluar carcinoma with macroscopic vascular invasion"],"prefix":"10.1016","volume":"187","author":[{"given":"Jeong Il","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Chul","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunju","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunki","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Wook","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Ki","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongho","family":"Hyun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaeseung","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung Ji","family":"Goh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moon Seok","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boram","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Min","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhong","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.109841_b0005","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.radonc.2023.109841_b0010","doi-asserted-by":"crossref","first-page":"211","DOI":"10.14701\/ahbps.22-044","article-title":"Incidence, mortality, and survival of liver cancer using Korea central cancer registry database: 1999\u20132019","volume":"26","author":"Hong","year":"2022","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.radonc.2023.109841_b0015","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1007\/s10620-007-9750-3","article-title":"Causes of death in patients with unresectable hepatocellular carcinoma","volume":"52","author":"Couto","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.radonc.2023.109841_b0020","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.radonc.2015.11.019","article-title":"Clinical impact of combined transarterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: An external validation study","volume":"118","author":"Yu","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109841_b0025","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.radonc.2023.109841_b0030","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.radonc.2019.08.009","article-title":"Combined transarterial chemoembolization and radiotherapy as a first-line treatment for hepatocellular carcinoma with macroscopic vascular invasion: Necessity to subclassify Barcelona Clinic Liver Cancer stage C","volume":"141","author":"Kim","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109841_b0035","doi-asserted-by":"crossref","first-page":"e0124434","DOI":"10.1371\/journal.pone.0124434","article-title":"Different survival of Barcelona clinic liver cancer stage C hepatocellular carcinoma patients by the extent of portal vein invasion and the type of extrahepatic spread","volume":"10","author":"Sinn","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.radonc.2023.109841_b0040","doi-asserted-by":"crossref","DOI":"10.1007\/s00262-023-03390-x","article-title":"Efficacy and safety of immune checkpoint inhibitors for hepatocellular carcinoma patients with macrovascular invasion or extrahepatic spread: a systematic review and meta-analysis of 54 studies with 6187 hepatocellular carcinoma patients","author":"Han","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.radonc.2023.109841_b0045","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.21873\/anticanres.12808","article-title":"Treatment of Na\u00efve HCC combined with segmental or subsegmental portal vein tumor thrombosis: Liver resection versus TACE followed by radiotherapy","volume":"38","author":"Yu","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.radonc.2023.109841_b0050","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus Bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2023.109841_b0055","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.jhep.2021.11.030","article-title":"Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma","volume":"76","author":"Cheng","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.radonc.2023.109841_b0060","doi-asserted-by":"crossref","unstructured":"2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma. Clin Mol Hepatol 2022;28:583-705. https:\/\/doi.org\/10.3350\/cmh.2022.0294.","DOI":"10.3350\/cmh.2022.0294"},{"key":"10.1016\/j.radonc.2023.109841_b0065","doi-asserted-by":"crossref","first-page":"e0210730","DOI":"10.1371\/journal.pone.0210730","article-title":"Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients","volume":"14","author":"Sinn","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.radonc.2023.109841_b0070","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3346\/jkms.2012.27.7.736","article-title":"Scheduled interval trans-catheter arterial chemoembolization followed by radiation therapy in patients with unresectable hepatocellular carcinoma","volume":"27","author":"Yu","year":"2012","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.radonc.2023.109841_b0075","doi-asserted-by":"crossref","first-page":"20120221","DOI":"10.1259\/bjr.20120221","article-title":"Evaluation of anatomical landmark position differences between respiration-gated MRI and four-dimensional CT for radiation therapy in patients with hepatocellular carcinoma","volume":"86","author":"Yu","year":"2013","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2023.109841_b0080","doi-asserted-by":"crossref","first-page":"558","DOI":"10.4097\/kja.19087","article-title":"Multicollinearity and misleading statistical results","volume":"72","author":"Kim","year":"2019","journal-title":"Korean J Anesthesiol"},{"key":"10.1016\/j.radonc.2023.109841_b0085","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1007\/s12072-021-10169-8","article-title":"Resubclassification and clinical management for Barcelona Clinic Liver Cancer Stage C hepatocellular carcinoma","volume":"15","author":"Lin","year":"2021","journal-title":"Hep Intl"},{"key":"10.1016\/j.radonc.2023.109841_b0090","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000367728","article-title":"Hong Kong consensus recommendations on the management of hepatocellular carcinoma","volume":"4","author":"Poon","year":"2015","journal-title":"Liver Cancer"},{"key":"10.1016\/j.radonc.2023.109841_b0095","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/jamaoncol.2017.5847","article-title":"Efficacy and safety of transarterial chemoembolization plus external beam radiotherapy vs sorafenib in hepatocellular carcinoma with macroscopic vascular invasion: A randomized clinical trial","volume":"4","author":"Yoon","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2023.109841_b0100","doi-asserted-by":"crossref","first-page":"541","DOI":"10.6004\/jnccn.2021.0022","article-title":"Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Benson","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.radonc.2023.109841_b0105","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jhep.2021.09.035","article-title":"Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score","volume":"76","author":"Scheiner","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.radonc.2023.109841_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2021.733343","article-title":"Effect of microvascular invasion on the prognosis in hepatocellular carcinoma and analysis of related risk factors: A two-center study","volume":"8","author":"Yanhan","year":"2021","journal-title":"Front Surg"},{"key":"10.1016\/j.radonc.2023.109841_b0115","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.21037\/atm-20-4698","article-title":"The effect of bile duct tumor thrombus on the long-term prognosis of hepatocellular carcinoma patients after liver resection: a systematic review and meta-analysis","volume":"8","author":"Feng","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.radonc.2023.109841_b0120","author":"Romero","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109841_b0125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3857\/roj.2022.00444","article-title":"Liquid biopsy using cfDNA to predict radiation therapy response in solid tumors","volume":"41","author":"Cho","year":"2023","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.radonc.2023.109841_b0130","first-page":"15","article-title":"Non-surgical locoregional therapies alone or in combination with systemic therapy in patients with hepatocellular carcinoma","author":"Chami","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.radonc.2023.109841_b0135","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2217\/fon-2020-0162","article-title":"IMbrave 050: a Phase III trial of atezolizumab plus bevacizumab in high-risk hepatocellular carcinoma after curative resection or ablation","volume":"16","author":"Hack","year":"2020","journal-title":"Future Oncol"},{"key":"10.1016\/j.radonc.2023.109841_b0140","article-title":"TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trial","volume":"5","author":"F\u00e9ray","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.radonc.2023.109841_b0145","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3857\/roj.2021.00934","article-title":"PIVKA-II as a surrogate marker for prognosis in patients with localized hepatocellular carcinoma receiving stereotactic body radiotherapy","volume":"40","author":"Cho","year":"2022","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.radonc.2023.109841_b0150","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/1754-9485.13309","article-title":"Stereotactic ablative radiotherapy for hepatocellular carcinoma: A systematic review and meta-analysis of local control, survival and toxicity outcomes","volume":"65","author":"Shanker","year":"2021","journal-title":"J Med Imaging Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109841_b0155","first-page":"14","article-title":"The current role of Stereotactic Body Radiation Therapy (SBRT) in Hepatocellular Carcinoma (HCC)","author":"Kimura","year":"2022","journal-title":"Cancers (Basel)"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023897353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023897353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:27:46Z","timestamp":1759123666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814023897353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":31,"alternative-id":["S0167814023897353"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109841","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"External validation of subclassification system and progression pattern analysis in hepatocelluar carcinoma with macroscopic vascular invasion","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109841","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109841"}}